Humoral and cellular immune responses to CoronaVac up to one year after vaccination
Coronavac is a widely used SARS-CoV-2 inactivated vaccine, but its long-term immune response assessment is still lacking. We evaluated SARS-CoV-2-specific immune responses, including T cell activation markers, antigen-specific cytokine production and antibody response following vaccination in 53 adu...
Main Authors: | Priscilla Ramos Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, Juliana Zanatta de Carvalho Dias, Mateus Vailant Thomazella, Amanda Cabral da Silva, Ana Carolina Soares de Oliveira, Arianne Fagotti Gusmão, Lilian Ferrari, Angela Carvalho Freitas, Elizabeth González Patiño, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Rami Scharf, Esper Georges Kallás, Cássia Gisele Terrassani Silveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1032411/full |
Similar Items
-
Metabolomics acts as a powerful tool for comprehensively evaluating vaccines approved under emergency: a CoronaVac retrospective study
by: Xinyu Liu, et al.
Published: (2023-07-01) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
by: Samar Samoud, et al.
Published: (2023-08-01) -
Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study
by: Thiago Cerqueira-Silva, et al.
Published: (2022-02-01) -
Sobre a eficácia da CoronaVac no Twitter: conversações e aspectos políticos
by: Carina Luisa Ochi Flexor, et al.
Published: (2022-12-01) -
Hybrid Immunity Results in Enhanced and More Sustained Antibody Responses after the Second Sinovac-CoronaVac Dose in a Brazilian Cohort: DETECTCoV-19 Cohort
by: Bárbara Batista Salgado, et al.
Published: (2023-09-01)